BioAtla BCAB
NASDAQ BCAB
$3.18 -0.05 (-1.55%)
At close: Aug 20, 2026 · 4:00 PM EDT

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026)

BioAtla (BCAB) posted quarterly Asset Utilization Ratio of 1.29 for Q4 2025, up 571.05% year-over-year from 0.19 in Q4 2024, and up 151.88% quarter-over-quarter from 0.51 in Q3 2025.

BioAtla (BCAB) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

BioAtla's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 1.29 for Q4 2025.

  • In Q4 2025, Asset Utilization Ratio rose 571.05% year-over-year to 1.29; the TTM figure through Dec 2025 stood at 1.29 (up 571.05% YoY), while the FY2025 annual figure was 0.07, down 44.83% from the prior year.
  • Asset Utilization Ratio for Q4 2025 stood at 1.29, up from 0.51 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 1.29 in Q4 2025, with the low at 0.0 in Q4 2021.
  • The 4-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.24.
  • The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio soared 11028.23% in 2024, then surged 204.1% in 2025.
  • BioAtla's Asset Utilization Ratio stood at 0.0 in 2021, then surged by 60.73% to 0.0 in 2023, then surged by 12602.08% to 0.19 in 2024, then surged by 571.05% to 1.29 in 2025.
  • Business Quant data shows BCAB's Asset Utilization Ratio at 1.29 in Q4 2025, 0.51 in Q3 2025, and 0.19 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.38
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 0.20
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.69
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.90
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.54
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.13
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.13
10 BioAtla 5.28 Mn 5.28 Mn - 1.73

Historic Data

Download Data
DateValue
Jun 30, 2026 1.73
Dec 31, 2025 1.29
Sep 30, 2025 0.51
Dec 31, 2024 0.19
Sep 30, 2024 0.17
Sep 30, 2023 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00